Dolby Laboratories (DLB) to Issue Quarterly Dividend of $0.36 on May 20th

Dolby Laboratories (NYSE:DLB) announced a quarterly dividend on Tuesday, April 28th. Shareholders of record on Tuesday, May 12th will be paid a dividend of 0.36 per share by the electronics maker on Wednesday, May 20th. This represents a c) dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Tuesday, May 12th.

Dolby Laboratories has increased its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend every year for the last 10 years. Dolby Laboratories has a payout ratio of 34.2% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Dolby Laboratories to earn $3.46 per share next year, which means the company should continue to be able to cover its $1.44 annual dividend with an expected future payout ratio of 41.6%.

Dolby Laboratories Stock Performance

Shares of NYSE DLB opened at $58.15 on Friday. The company has a market cap of $5.56 billion, a P/E ratio of 22.98 and a beta of 0.86. The firm’s fifty day moving average is $62.24 and its two-hundred day moving average is $64.27. Dolby Laboratories has a 52-week low of $55.73 and a 52-week high of $78.28.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. The company had revenue of $395.63 million for the quarter, compared to the consensus estimate of $385.80 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. Dolby Laboratories’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, analysts forecast that Dolby Laboratories will post 3.22 EPS for the current fiscal year.

Insiders Place Their Bets

In other Dolby Laboratories news, SVP John D. Couling sold 7,666 shares of Dolby Laboratories stock in a transaction on Tuesday, May 5th. The shares were sold at an average price of $57.55, for a total value of $441,178.30. Following the completion of the transaction, the senior vice president directly owned 118,353 shares of the company’s stock, valued at $6,811,215.15. This trade represents a 6.08% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CAO Ryan Nicholson sold 2,667 shares of Dolby Laboratories stock in a transaction on Friday, February 13th. The stock was sold at an average price of $66.38, for a total transaction of $177,035.46. Following the completion of the transaction, the chief accounting officer directly owned 36,956 shares of the company’s stock, valued at $2,453,139.28. The trade was a 6.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 18,021 shares of company stock valued at $1,090,741 in the last three months. Corporate insiders own 37.93% of the company’s stock.

Hedge Funds Weigh In On Dolby Laboratories

Hedge funds have recently added to or reduced their stakes in the company. Ashton Thomas Private Wealth LLC bought a new position in Dolby Laboratories during the 3rd quarter valued at about $615,000. JPMorgan Chase & Co. grew its holdings in Dolby Laboratories by 81.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 312,028 shares of the electronics maker’s stock valued at $22,582,000 after purchasing an additional 139,900 shares during the last quarter. Alps Advisors Inc. grew its holdings in Dolby Laboratories by 6.7% during the 3rd quarter. Alps Advisors Inc. now owns 281,532 shares of the electronics maker’s stock valued at $20,374,000 after purchasing an additional 17,592 shares during the last quarter. Meeder Asset Management Inc. grew its holdings in Dolby Laboratories by 787.1% during the 3rd quarter. Meeder Asset Management Inc. now owns 27,526 shares of the electronics maker’s stock valued at $1,992,000 after purchasing an additional 24,423 shares during the last quarter. Finally, Summit Creek Advisors LLC grew its holdings in Dolby Laboratories by 24.9% during the 3rd quarter. Summit Creek Advisors LLC now owns 125,034 shares of the electronics maker’s stock valued at $9,049,000 after purchasing an additional 24,905 shares during the last quarter. 58.56% of the stock is currently owned by institutional investors.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.